A novel cytoprotective peptide protects mesenchymal stem cells against mitochondrial dysfunction and apoptosis

Shuo Wang1,2, Chao Zhang1,2, Sidikejiang Niyazi1,2

  • 1Department of Urology, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai, 200032, China.

Abstract

Insights

A novel peptide, CHBP, enhances mesenchymal stem cell (MSC) survival against nutrient starvation by protecting mitochondria. This study reveals CHBP activates the Nrf2/Sirt3/FoxO3a pathway, improving MSC therapeutic potential.

Area of Science:

  • Cell Biology
  • Regenerative Medicine
  • Biochemistry

Background:

  • Mesenchymal stem cells (MSCs) show promise for treating diseases but suffer from poor survival due to nutrient starvation.
  • This survival limitation hinders the clinical application of MSC-based therapies.
  • Understanding mechanisms to enhance MSC resilience is crucial for advancing cell-based treatments.

Purpose of the Study:

  • To investigate the protective effects of a novel kidney protective peptide, CHBP, on mesenchymal stem cells (MSCs) under nutrient starvation conditions.
  • To elucidate the underlying molecular mechanisms responsible for CHBP-mediated protection of MSCs.
  • To assess the impact of CHBP on MSC viability, apoptosis, and mitochondrial function during starvation.

Main Methods:

  • MSCs were exposed to serum deprivation with varying concentrations of CHBP.
  • Cell viability, apoptosis, reactive oxygen species (ROS) generation, and mitochondrial function were assessed.
  • Key pathway proteins (Nrf2, Sirt3, FoxO3a) were analyzed using Western blot.

Main Results:

  • CHBP significantly improved MSC viability and reduced apoptosis in a dose-dependent manner.
  • CHBP alleviated starvation-induced mitochondrial dysfunction, including reducing ROS and restoring membrane potential.
  • The protective effect of CHBP was linked to the activation of the Nrf2/Sirt3/FoxO3a pathway, with Sirt3 knockdown partially reversing the protection.

Conclusions:

  • CHBP effectively protects mesenchymal stem cells against starvation-induced mitochondrial damage and apoptosis.
  • The Nrf2/Sirt3/FoxO3a pathway plays a significant role in mediating CHBP's protective effects.
  • CHBP holds potential for enhancing MSC survival and therapeutic efficacy in clinical applications.

Related Concept Videos

Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.7K
Stem Cell Niche01:26

Stem Cell Niche

The stem cell niche is the dynamic microenvironment where stem cells reside. Inside these niches, the cells may remain undifferentiated, undergo high self-renewal, or become lineage-specific progenitors. Stem cells coexist with other niche cells, such as stromal cells. They also interact closely with the ECM. Cell-cell and cell-matrix communication occur via adhesion molecules or soluble factors that signal the stem cells and determine their fate. Stromal cells also provide survival signals to...
6.5K
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.5K